🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s ALT Holdings & Trades

First Buy
Q1 2023
Duration Held
11 Quarters
Largest Add
Q2 2026
+1.14 M Shares
Current Position
63,485 Shares
$181,566 Value

Cliff Asness's ALT Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 63,485 shares of Altimmune, Inc. (ALT) worth $181,566, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.

Based on 13F filings, Cliff Asness has maintained a strategic position in ALT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.14 M shares. Largest reduction occurred in Q3 2026, reducing 1.16 M shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Altimmune (ALT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Altimmune (ALT) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 -1.16 M Reduce 94.80% 63,485 $2.86
Q2 2026 +1.14 M Add 1328.78% 1.22 M $3.04
Q1 2026 +64,307 Add 304.10% 85,454 $3.08
Q4 2025 +21,147 New Buy 21,147 $3.61
Q1 2025 -12,577 Sold Out 0 $0.00
Q4 2024 -11,308 Reduce 47.34% 12,577 $7.21
Q3 2024 -17,494 Reduce 42.28% 23,885 $6.14
Q2 2024 -19,315 Reduce 31.82% 41,379 $6.65
Q1 2024 +60,694 New Buy 60,694 $10.18
Q2 2023 -21,662 Sold Out 0 $0.00
Q1 2023 +21,662 New Buy 21,662 $4.22

Cliff Asness's Altimmune Investment FAQs

Cliff Asness first purchased Altimmune, Inc. (ALT) in Q1 2023, acquiring 21,662 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Altimmune, Inc. (ALT) for 11 quarters since Q1 2023.

Cliff Asness's largest addition to Altimmune, Inc. (ALT) was in Q2 2026, adding 1,220,949 shares worth $3.71 M.

According to the latest 13F filing for Q3 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 63,485 shares of Altimmune, Inc. (ALT), valued at approximately $181,566.

As of the Q3 2026 filing, Altimmune, Inc. (ALT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Altimmune, Inc. (ALT) was 1,220,949 shares, as reported at the end of Q2 2026.